RxDoctor Payments DataLook up a doctor →

Thomas Holmes, MD

Neuromusculoskeletal Medicine & OMM · Marietta, GANPI 1326131467

Payments from drug & device makers

$108,107in general payments, 2019–2025

Across 983 payments — averaging $109.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$29K
  • Jazz Pharmaceuticals Inc.$28K
  • Greenwich Biosciences, Inc.$20K
  • UCB, Inc.$19K
  • SK Life Science, Inc.$3K
  • Argenx US, Inc.$711
  • plus $8K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)248$29,319
Jazz Pharmaceuticals Inc.60$27,826
Greenwich Biosciences, Inc.37$19,912
UCB, Inc.173$19,379
SK Life Science, Inc.16$2,850
Argenx US, Inc.45$711
Neurelis, Inc.14$579
Teva Pharmaceuticals USA, Inc.33$479
Acadia Pharmaceuticals Inc23$425
Novartis27$414
Supernus Pharmaceuticals, Inc.21$404
Pfizer22$400
Biogen22$395
Amgen(2 entities)23$386
Upsher-smith Laboratories LLC20$316
AstraZeneca16$316
Eisai Inc.11$305
MDD US Operations, LLC8$255
Sunovion Pharmaceuticals Inc.15$234
EMD Serono, Inc.11$230
Octapharma USA, Inc.4$222
GE HealthCare12$196
Bristol Myers Squibb9$191
Amneal Pharmaceuticals LLC11$169
Sanofi9$169
Acorda Therapeutics, Inc7$144
Livanova USA, Inc.1$137
Sumitomo Pharma America, Inc.5$124
Neurocrine Biosciences, Inc.5$111
Otsuka America Pharmaceutical, Inc.4$107
TG Therapeutics, Inc.4$93
Lundbeck LLC4$91
Lilly USA, LLC5$91
Johnson & Johnson(2 entities)4$87
Biohaven Pharmaceuticals, Inc.4$79
Axsome Therapeutics, Inc.3$76
CSL Behring3$67
Biohaven Pharmaceutical Holding Company Ltd.3$65
Avanir Pharmaceuticals, Inc.4$62
Grifols USA, LLC3$57
Impel Pharmaceuticals LLC3$51
Harmony Biosciences LLC2$49
Promius Pharma LLC3$46
Abbott3$43
Neuropace, Inc.1$41
Bausch Health US, LLC2$40
Kyowa Kirin, Inc.2$40
Banner Life Sciences, LLC2$38
Arbor Pharmaceuticals, Inc.2$33
Avion Pharmaceuticals2$32
Springworks Therapeutics, Inc.1$31
Adamas Pharmaceuticals, Inc.2$29
Aquestive Therapeutics, Inc.1$22
Microtransponder, Inc.1$20
Cycle Pharmaceuticals Inc1$19
Takeda Pharmaceuticals U.S.A., Inc.1$19
GSK1$19
Azurity Pharmaceuticals, Inc.1$16
Impel Pharmaceuticals Inc.1$16
Mallinckrodt Enterprises LLC1$15

How this compares

Too few neuromusculoskeletal medicine & omm providers in Georgiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$221,420
Medicare patients
979
Services billed
2,029

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neuromusculoskeletal medicine & omm in Marietta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →